Low Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients.

TitleLow Socioeconomic Status, Adverse Gene Expression Profiles, and Clinical Outcomes in Hematopoietic Stem Cell Transplant Recipients.
Publication TypeJournal Article
Year of Publication2016
AuthorsKnight JM, J Rizzo D, Logan BR, Wang T, Arevalo JMG, Ma J, Cole SW
JournalClin Cancer Res
Volume22
Issue1
Pagination69-78
Date Published2016 Jan 1
ISSN1078-0432
Abstract

PURPOSE: Low socioeconomic status (SES) is associated with adverse outcomes among unrelated donor hematopoietic stem cell transplant (HCT) recipients, but the biologic mechanisms contributing to this health disparity are poorly understood. Therefore, we examined whether social environment affects expression of a stress-related gene expression profile known as the conserved transcriptional response to adversity (CTRA), which involves upregulation of proinflammatory genes and downregulation of genes involved in type I IFN response and antibody synthesis.

EXPERIMENTAL DESIGN: We compared pretransplant leukocyte CTRA gene expression between a group of 78 high versus low SES recipients of unrelated donor HCT for acute myelogenous leukemia in first remission. Post hoc exploratory analyses also evaluated whether CTRA gene expression was associated with poor clinical outcomes.

RESULTS: Peripheral blood mononuclear cells collected pre-HCT from low SES individuals demonstrated significant CTRA upregulation compared with matched HCT recipients of high SES. Promoter-based bioinformatics implicated distinct patterns of transcription factor activity, including increased CREB signaling and decreased IRF and GR signaling. High expression of the CTRA gene profile was also associated with increased relapse risk and decreased leukemia-free survival.

CONCLUSIONS: Low SES is associated with increased expression of the CTRA gene profile, and CTRA gene expression is associated with adverse HCT clinical outcomes. These findings provide a biologic framework within which to understand how social environmental conditions may influence immune function and clinical outcomes in allogeneic HCT.

DOI10.1158/1078-0432.CCR-15-1344
Alternate JournalClin. Cancer Res.
PubMed ID26286914
PubMed Central IDPMC4703514
Grant List5U10HL069294 / HL / NHLBI NIH HHS / United States
5U24-CA076518 / CA / NCI NIH HHS / United States
F32 AG048681 / AG / NIA NIH HHS / United States
HHSH250201200016C / / PHS HHS / United States
P30 AG017265 / AG / NIA NIH HHS / United States
P30 AG017265 / AG / NIA NIH HHS / United States
U10 HL069294 / HL / NHLBI NIH HHS / United States
U24 CA076518 / CA / NCI NIH HHS / United States